Ingolf Cascorbi

Implementation and obstacles of pharmacogenetics in clinical practice: An international survey

I. Cascorbi, N. Zgheib, E. Abou Diwan, 2019, British journal of clinical pharmacology.

Elimination half-life of anti-Müllerian hormone.

I. Cascorbi, C. Messini, K. Dafopoulos, 2012, The Journal of clinical endocrinology and metabolism.

Phenotype–Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism

Meike Kaehler, R. Böhm, Henrike Bruckmueller, 2024, Clinical pharmacology and therapeutics.

Drug Interactions of Tetrahydrocannabinol and Cannabidiol in Cannabinoid Drugs: Recommendations for Clinical Practice.

Ingolf Cascorbi, Thomas Herdegen, 2023, Deutsches Arzteblatt international.

Molecular biomarkers of leukemia: convergence-based drug resistance mechanisms in chronic myeloid leukemia and myeloproliferative neoplasms

N. von Bubnoff, S. P. Gorantla, Meike Kaehler, 2024, Frontiers in pharmacology.

Liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity

P. Pfluger, S. Wolter, Meike Kaehler, 2024, bioRxiv.

Drug Interactions

Ingolf Cascorbi, 2021, Encyclopedia of Molecular Pharmacology.